Heparin-Coated Catheters and Reduction of Catheter-Related Bloodstream Infection in Sepsis Patients

Authors

  • Varga P Department of Intensive Care Medicine, Pavol Jozef Safarik University, Kosice, Slovakia Author
  • Oja K Department of Infectious Diseases, Tallinn University of Technology, Tallinn, Estonia Author
  • Jansen J Department of Clinical Microbiology, Radboud University, Nijmegen, Netherlands Author

DOI:

https://doi.org/10.5281/zenodo.22644310

Keywords:

heparin-coated catheter, catheter-related bloodstream infection, central venous catheter, sepsis, catheter thrombosis prevention

Abstract

Background: Central venous catheters are essential to the resuscitation and monitoring of sepsis and septic shock, but the same
indwelling device is a leading modifiable source of catheter-related bloodstream infection (CRBSI), a risk compounded in septic
patients by prolonged dwell time and sepsis-associated coagulopathy that links catheter thrombosis mechanistically to catheter
infection. Objective: This narrative review synthesizes the published evidence on heparin-coated and heparin-bonded central
venous and related catheters as a strategy for reducing CRBSI and catheter thrombosis, with particular attention to critically ill
and sepsis-adjacent populations. Methods: Peer-reviewed randomized trials, comparative cohort studies, and Cochrane systematic
reviews addressing heparin-coated or heparin-bonded catheters, alongside foundational sepsis, catheter-infection epidemiology,
and guideline literature, were identified and synthesized thematically around pathophysiological rationale, adult and critically ill
trial evidence, pediatric and systematic review evidence, hemodialysis-catheter evidence, and implementation context. Findings:
Heparin coating reduces CRBSI relative to uncoated catheters, with a randomized hematology-oncology trial reporting infection
rates of 2.5% versus 9.1% (0.9 versus 3.5 episodes per 1,000 catheter-days) and a pooled pediatric Cochrane analysis reporting a
number needed to treat of 6 to prevent one CRBSI event and 13 to prevent one catheter occlusion event. Against newer antiseptic-
and antibiotic-impregnated catheters, however, heparin-coated devices have shown an inconsistent or unfavorable comparative
advantage in general critically ill and pediatric populations, and heparin coating's infection benefit and thrombosis benefit appear
to dissociate in some catheter types, including tunneled hemodialysis catheters. Conclusions: Heparin-coated catheters are a
mechanistically coherent and evidence-supported, but not uniformly superior, adjunct to bundle-based CRBSI prevention in sepsis;
their comparative role relative to antiseptic-impregnated catheters, and their specific benefit in coagulopathic, thrombosis-prone
septic patients, warrants dedicated prospective evaluation.

References

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8):801-810, DOI:10.1001/jama.2016.0287.

Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K (2009) International Study of the Prevalence and Outcomes of Infection in Intensive Care Units. JAMA, 302(21):2323-2329, DOI:10.1001/jama.2009.1754.

Maki DG, Kluger DM, Crnich CJ (2006) The Risk of Bloodstream Infection in Adults with Different Intravascular Devices: A Systematic Review of 200 Published Prospective Studies. Mayo Clinic Proceedings, 81(9):1159-1171, DOI:10.4065/81.9.1159.

Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE (2001) Guidelines for the Management of Intravascular Catheter-Related Infections. Clinical Infectious Diseases, 32(9):1249-1272, DOI:10.1086/320001.

O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S (2011) Summary of recommendations: guidelines for the prevention of intravascular catheter-related infections. Clinical Infectious Diseases, 52(9):1087-1099, DOI:10.1093/cid/cir138.

Liu L, Yu H, Wang L, Zhou D, Duan X, Zhang X, Yin J, Luan S, Shi H (2024) Heparin-network-mediated long-lasting coatings on intravascular catheters for adaptive antithrombosis and antibacterial infection. Nature Communications, 15(1):107, DOI:10.1038/s41467-023-44478-3.

Abdelkefi A, Achour W, Ben Othman T, Ladeb S, Torjman L, Lakhal A, Ben Hassen A, Hsairi M, Ben Abdeladhim A (2007) Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection. Journal of Supportive Oncology, 5(6):273-278, DOI:N/A.

Carrasco MN, Bueno A, de las Cuevas C, Jimenez S, Salinas I, Sartorius A, Recio T, Generelo M, Ruiz-Ocaña F (2004) Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients. Intensive Care Medicine, 30(4):633-638, DOI:10.1007/s00134-003-2093-4.

Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G (1999) A comparison of two antimicrobial-impregnated central venous catheters. New England Journal of Medicine, 340(1):1-8, DOI:10.1056/NEJM199901073400101.

Randolph AG, Cook DJ, Gonzales CA, Andrew M (1998) Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest, 113(1):165-171, DOI:10.1378/chest.113.1.165.

Pierce CM, Wade A, Mok Q (2000) Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Medicine, 26(7):967-972, DOI:10.1007/s001340051289.

Shah PS, Shah N (2014) Heparin-bonded catheters for prolonging the patency of central venous catheters in children. Cochrane Database of Systematic Reviews, 2014(2):CD005983, DOI:10.1002/14651858.CD005983.pub3.

Lai NM, Chaiyakunapruk N, Lai NA, O'Riordan E, Pau WS, Saint S (2016) Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database of Systematic Reviews, 2016(3):CD007878, DOI:10.1002/14651858.CD007878.pub3.

López-Briz E, Ruiz Garcia V, Cabello JB, Bort-Marti S, Carbonell Sanchis R, Burls A (2014) Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults. Cochrane Database of Systematic Reviews, 2014(10):CD008462, DOI:10.1002/14651858.CD008462.pub2.

Jain G, Allon M, Saddekni S, Barker-Finkel J, Maya ID (2009) Does heparin coating improve patency or reduce infection of tunneled dialysis catheters? Clinical Journal of the American Society of Nephrology, 4(11):1787-1790, DOI:10.2215/CJN.03920609.

Clark TWI, Jacobs D, Charles HW, Kovacs S, Aquino T, Erinjeri J, Benstein JA (2009) Comparison of heparin-coated and conventional split-tip hemodialysis catheters. CardioVascular and Interventional Radiology, 32(4):703-706, DOI:10.1007/s00270-009-9608-5.

Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C (2006) An intervention to decrease catheter-related bloodstream infections in the ICU. New England Journal of Medicine, 355(26):2725-2732, DOI:10.1056/NEJMoa061115.

Gilbert RE, Mok Q, Dwan K, Harron K, Moitt T, Millar M, Ramnarayan P, Tibby SM, Hughes D, Gamble C (2016) Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial. The Lancet, 387(10029):1732-1742, DOI:10.1016/S0140-6736(16)00340-8.

Downloads

Published

2025-12-19